Intrauterine Stent for Uterine Abnormalities
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to find the best way to prevent scar tissue inside the uterus after surgery to repair a uterine septum (a wall of tissue that divides the uterus). Researchers are testing whether placing a small balloon inside the uterus after surgery can prevent scar tissue formation. Participants will either have the balloon placed or not after their surgery. Women scheduled for a specific type of uterine surgery to remove a septum, with at least half of their uterus affected, might be suitable for this trial. As an unphased trial, this study allows participants to contribute to innovative research that could enhance surgical outcomes for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the intrauterine stent placement is safe for preventing uterine abnormalities?
Research has shown that intrauterine stents, like the one being studied, are generally safe. For instance, one study found that a similar device, the Jada device, successfully controlled bleeding in 94% of cases, indicating it is well-tolerated. Another study examined an intrauterine balloon stent and found it to be safe, although some participants experienced infections. About one-third of the balloon stent group had positive microorganism cultures, meaning some bacteria were found, but they were not necessarily harmful.
These findings suggest that while some risks, such as possible infections, exist, intrauterine stents are generally considered safe and effective for many patients. Always discuss any concerns with a healthcare provider before joining a trial.12345Why are researchers excited about this trial?
Researchers are excited about the intrauterine stent technique for uterine abnormalities because it offers a novel approach compared to standard treatments like hormonal therapy and surgical interventions. Unlike existing options, this method involves the placement of an inflated intrauterine pediatric Foley catheter, which stays in place for 7-10 days post-surgery. This mechanical approach may provide physical support and potentially improve surgical outcomes without relying solely on hormone-based therapies. By providing a new delivery method, this technique could offer a quicker and more localized solution, reducing the reliance on systemic treatments.
What evidence suggests that this trial's treatments could be effective for preventing internal scar tissue after septum removal?
Research has shown that using an intrauterine stent, similar to a small tube, can help prevent internal scar tissue after surgery. In this trial, one group of participants will receive an intraoperative placement of an inflated intrauterine pediatric Foley catheter, a type of stent, which will remain in place for 7-10 days post-surgery. Studies indicate that placing a stent can effectively reduce the risk of scar tissue recurrence and help restore the uterus's shape. One study found that the chances of ongoing pregnancy were similar between those using a balloon and those using an intrauterine device (IUD), suggesting the balloon is as effective as other methods. Another study found that using a stent is effective and easy for treating mild-to-moderate internal scar tissue. Overall, these findings suggest that intrauterine stents may help reduce scar tissue after surgery.26789
Who Is on the Research Team?
Glenn Schattman, MD
Principal Investigator
Weill Medical College of Cornell University
Are You a Good Fit for This Trial?
This trial is for individuals with uterine conditions like scarring (synechiae), a septate uterus, other abnormalities, or Asherman's Syndrome. Specific inclusion and exclusion criteria are not provided but would typically detail the precise characteristics required for participation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery and Immediate Post-operative Care
Participants undergo hysteroscopic septum resection and are randomized to receive either an intrauterine foley catheter balloon with hormonal supplementation or hormonal supplementation only
Post-operative Monitoring
Participants undergo a post-operative in-clinic 3D saline sonogram to assess adhesion formation
Follow-up
Participants are monitored for long-term reproductive outcomes, including pregnancy achievement
What Are the Treatments Tested in This Trial?
Interventions
- Hormonal Therapy Agent
- Intrauterine Stent Placement
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor